Cui and Zhu (2016) prepared doxorubicin-loaded PLA nanoparticles, covered with polyethylene imine (PEI) that was functionalized with Herceptin, a monoclonal antibody, which targets the human epidermal growth factor receptor 2 (HER2), overexpressed in breast cancer. The gene discussed is ERBB2; the disease is breast cancer.